Jacobs Levy Equity Management
CRDF icon

Jacobs Levy Equity Management’s Cardiff Oncology CRDF Stock Holding History

Jacobs Levy Equity Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-92,269
Closed -$291K – 994
2025
Q2 		$291K Sell
92,269
-303,849
-77% -$927K ﹤0.01% 938
2025
Q1 		$1.24M Buy
396,118
+256,264
+183% +$1.01M ﹤0.01% 770
2024
Q4 		$607K Buy
+139,854
New +$437K ﹤0.01% 788
2023
Q4 		– Sell
-65,558
Closed -$91.1K – 996
2023
Q3 		$91.1K Sell
65,558
-31,495
-32% -$53.1K ﹤0.01% 943
2023
Q2 		$143K Buy
97,053
+55,576
+134% +$89.6K ﹤0.01% 938
2023
Q1 		$68.4K Buy
+41,477
New +$71.2K ﹤0.01% 937

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jacobs Levy Equity Management's CRDF Position: Q3 2025 in Review

Jacobs Levy Equity Management sold out of Cardiff Oncology (CRDF) in Q3 2025, closing a stake of 92,269 shares — an estimated $291K sold.

Jacobs Levy Equity Management first reported a position in CRDF in Q1 2023 and held it in 6 quarters. The position peaked at $1.24M in Q1 2025. 112 funds tracked by Wall St. Rank hold CRDF as of Q3 2025.

  • Jacobs Levy Equity Management reported no remaining Cardiff Oncology position as of Q3 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 92,269 Cardiff Oncology shares in Q3 2025, an estimated $291K.
  • Jacobs Levy Equity Management first reported a position in Cardiff Oncology in Q1 2023 and held it in 6 quarters.
  • Jacobs Levy Equity Management's Cardiff Oncology position peaked at $1.24M in Q1 2025.
  • 112 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.